Brea and coworkers[20] have analyzed the TLR2 and TLR4 expression at a protein level by flowcytometry in blood samples from patients with ischemic stroke (at 24-h, 72-h and 7-day time points), as well as in healthy controls subjects. The gene discussed is TLR2; the disease is ischemic stroke.